Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq

被引:89
作者
Shih, Andrew J. [1 ]
Menzin, Andrew [2 ]
Whyte, Jill [2 ]
Lovecchio, John [2 ]
Liew, Anthony [1 ]
Khalili, Houman [1 ]
Bhuiya, Tawfiqul [2 ]
Gregersen, Peter K. [1 ,2 ]
Lee, Annette T. [1 ,2 ]
机构
[1] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA
[2] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA
关键词
CXCL12-CXCR4 AXIS PROMOTES; COLLAGEN TYPE-IV; BREAST-CANCER; MONOCLONAL-ANTIBODY; COMPLEMENT-SYSTEM; GENE-EXPRESSION; S100; PROTEINS; IFN-GAMMA; PROLIFERATION; CHEMOTHERAPY;
D O I
10.1371/journal.pone.0206785
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Here we investigated different cell populations within ovarian cancer using single-cell RNA seq: fourteen samples from nine patients with differing grades (high grade, low grade and benign) as well as different origin sites (primary and metastatic tumor site, ovarian in origin and fallopian in origin). We were able to identify sixteen distinct cell populations with specific cells correlated to high grade tumors, low grade tumors, benign and one population unique to a patient with a breast cancer relapse. Furthermore the proportion of these populations changes from primary to metastatic in a shift from mainly epithelial cells to leukocytes with few cancer epithelial cells in the metastases. Differential gene expression shows myeloid lineage cells are the primary cell group expressing soluble factors in primary samples while fibroblasts do so in metastatic samples. The leukocytes that were captured did not seem to be suppressed through known pro-tumor cytokines from any of the cell populations. Single cell RNA-seq is necessary to de-tangle cellular heterogeneity for better understanding of ovarian cancer progression.
引用
收藏
页数:17
相关论文
共 74 条
[1]   IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer [J].
Abiko, K. ;
Matsumura, N. ;
Hamanishi, J. ;
Horikawa, N. ;
Murakami, R. ;
Yamaguchi, K. ;
Yoshioka, Y. ;
Baba, T. ;
Konishi, I. ;
Mandai, M. .
BRITISH JOURNAL OF CANCER, 2015, 112 (09) :1501-1509
[2]   The role of the complement system in cancer [J].
Afshar-Kharghan, Vahid .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03) :780-789
[3]  
[Anonymous], 2017, R LANG ENV STAT COMP
[4]  
[Anonymous], PAUL TOLS NOTES COLO
[5]   Angiogenesis and Collagen Type IV Expression in Different Endothelial Cell Culture Systems [J].
Bahramsoltani, M. ;
Slosarek, I. ;
De Spiegelaere, W. ;
Plendl, J. .
ANATOMIA HISTOLOGIA EMBRYOLOGIA, 2014, 43 (02) :103-115
[6]   REACTIVITY OF A MONOCLONAL-ANTIBODY WITH HUMAN OVARIAN-CARCINOMA [J].
BAST, RC ;
FEENEY, M ;
LAZARUS, H ;
NADLER, LM ;
COLVIN, RB ;
KNAPP, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1331-1337
[7]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[8]   Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy [J].
Bellone, S. ;
Tassi, R. ;
Betti, M. ;
English, D. ;
Cocco, E. ;
Gasparrini, S. ;
Bortolomai, I. ;
Black, J. D. ;
Todeschini, P. ;
Romani, C. ;
Ravaggi, A. ;
Bignotti, E. ;
Bandiera, E. ;
Zanotti, L. ;
Pecorelli, S. ;
Ardighieri, L. ;
Falchetti, M. ;
Donzelli, C. ;
Siegel, E. R. ;
Azodi, M. ;
Silasi, D-A ;
Ratner, E. ;
Schwartz, P. E. ;
Rutherford, T. J. ;
Santin, A. D. .
BRITISH JOURNAL OF CANCER, 2013, 109 (02) :462-471
[9]   Ascitic complement system in ovarian cancer [J].
Bjorge, L ;
Hakulinen, J ;
Vintermyr, OK ;
Jarva, H ;
Jensen, TS ;
Iversen, OE ;
Meri, S .
BRITISH JOURNAL OF CANCER, 2005, 92 (05) :895-905
[10]   S100 proteins in cancer [J].
Bresnick, Anne R. ;
Weber, David J. ;
Zimmer, Danna B. .
NATURE REVIEWS CANCER, 2015, 15 (02) :96-109